Kukje Pharma Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was KRW 30,162.65 million compared to KRW 29,833.84 million a year ago. Net income was KRW 1,456.73 million compared to KRW 806.26 million a year ago. Basic earnings per share from continuing operations was KRW 72.381 compared to KRW 40 a year ago. Diluted earnings per share from continuing operations was KRW 72.381 compared to KRW 40 a year ago. Basic earnings per share was KRW 72.381 compared to KRW 40 a year ago.
For the nine months, sales was KRW 95,654.59 million compared to KRW 86,844.39 million a year ago. Net income was KRW 4,790.37 million compared to KRW 1,785.35 million a year ago. Basic earnings per share from continuing operations was KRW 236.1905 compared to KRW 87.619 a year ago. Diluted earnings per share from continuing operations was KRW 236.1905 compared to KRW 87.619 a year ago. Basic earnings per share was KRW 236.1905 compared to KRW 87.619 a year ago.